FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

PATH swells in size

Xconomy outlines the rapid growth of Seattle-based PATH, which has used millions in grants from the Gates Foundation to pursue research into new vaccines. Since 2000, PATH has grown from 240 employees to a staff of 775 and its annual budget has hit $240 million. Report

Bookmark and Share
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about PATH Malaria Vaccine Initiative  


Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.